Belgium (BE)

Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): health-related quality-of-life results from a double-blind, randomised, controlled, phase 3 trial. (2021) Bottomley A, Coens C, Mierzynska J, Blank CU, Mandalà M, Long GV, Atkinson VG, et al. Journal article Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial. (2021) Eggermont AM, Blank CU, Mandalà M, Long GV, Atkinson VG, Dalle S, Haydon AM, et al. Journal article Resolution of enthesitis by guselkumab and relationships to disease burden: 1-year results of two phase 3 psoriatic arthritis studies. (2021) Mcgonagle D, Mcinnes IB, Deodhar A, Schett G, Shawi M, Kafka S, Karyekar CS, et al. Journal article Clinician Well-Being-Addressing Global Needs for Improvements in the Health Care Field: A Joint Opinion From the American College of Cardiology, American Heart Association, European Society of Cardiology, and the World Heart Federation. (2021) Mehta LS, Elkind MSV, Achenbach S, Pinto FJ, Poppas A Journal article, Letter The Tobacco Endgame-Eradicating a Worsening Epidemic: A Joint Opinion From the American Heart Association, World Heart Federation, American College of Cardiology, and the European Society of Cardiology. (2021) Willett J, Achenbach S, Pinto FJ, Poppas A, Elkind MSV Journal article, Editorial The tobacco endgame-eradicating a worsening epidemic. (2021) Willett J, Achenbach S, Pinto FJ, Poppas A, Elkind MS Journal article CyberGlove for clinical use? (2021) Michaelis J, Reiher I, Heinrich S, Coppers B, Schett G, Kleyer A, Elewaut D, et al. Conference contribution, Abstract of a poster Adjuvant Chemotherapy for Muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis of Individual Participant Data from Randomised Controlled Trials (2021) Burdett S, Fisher DJ, Vale CL, Bono AV, Clarke NW, Cognetti F, Collette L, et al. Journal article, Review article Modeling dysphonia severity as a function of roughness and breathiness ratings in the GRBAS scale (2021) Ferrer CA, Aragón E, Hdez-Díaz ME, De Bodt MS, Cmejla R, Englert M, Behlau M, Nöth E Conference contribution Safety and efficacy of combining biologics or small molecules for inflammatory bowel disease or immune-mediated inflammatory diseases: A European retrospective observational study (2021) Goessens L, Colombel JF, Outtier A, Ferrante M, Sabino J, Judge C, Saeidi R, et al. Journal article